Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TCT 2018

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Joo Myung Lee

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, iMR, and WIA In Evaluating Culprit Lesion and Vessel Flow In STEMI

Presenter: Morton J. Kern, Graham Nichol, Kalpa De Silva

September 24, 2018

Presentation TCT 2018

Is There a Role for FFR (or iFR) Side Branch Assessment?

Presenter: Antonio Colombo, Jean Fajadet, Nick Curzen

September 23, 2018

Presentation TCT 2018

Coronary Physiology: FFR and iFR

Presenter: David A. Cox, Henning Kelbæk, Allen Jeremias

September 21, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

News Daily News

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

Caitlin E. Cox

April 17, 2018

News Conference News ACC 2018

iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis

Caitlin E. Cox

March 10, 2018

News Conference News ACC 2018

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

Shelley Wood

March 10, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

Advertisement

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

The Role of FFR, iFR, iMR, and WIA In Evaluating Culprit Lesion and Vessel Flow In STEMI

Is There a Role for FFR (or iFR) Side Branch Assessment?

Coronary Physiology: FFR and iFR

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

TCTMD’s Top 10 Most Popular Stories for April 2018

iFR Pullback Provides Roadmap for CAD Severity, Predicts Hemodynamics Post-PCI

iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis

ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content